March 27, 2024 · Form 4 insider transaction
Foster Karen A. sold 395 shares of BioLife Solutions, Inc. at $17.99 per share, a transaction worth $7.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.